3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
12
Oropharyngeal Neoplasms
12
Lung Neoplasms
9
Carcinoma
8
Mouth Neoplasms
7
Laryngeal Neoplasms
7
Mesothelioma, Malignant
6
Hypopharyngeal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Uterine Cervical Neoplasms
5
Nasopharyngeal Carcinoma
5
Urinary Bladder Neoplasms
4
Pancreatic Neoplasms
4
Triple Negative Breast Neoplasms
3
Salivary Gland Neoplasms
3
Lymphoid Interstitial Pneumonia
3
Gallbladder Neoplasms
3
Testicular Neoplasms
2
Seminoma
2
Medulloblastoma
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Breast Neoplasms
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Teratoma
1
Interventions
Carboplatin
3
durvalumab
2
Tretinoin
2
Paclitaxel
2
Irinotecan
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
tegafur-gimeracil-oteracil
1
talazoparib
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Surgical Procedures, Operative
1
Standard of Care
1
STA 9090
1
SGN-LIV1A
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Platinum
×
90 days
×
Clear all
No trials found.